Garner B, Shaw D C, Lindner R A, Carver J A, Truscott R J
Australian Cataract Research Foundation, University of Wollongong, Wollongong, NSW, Australia.
Biochim Biophys Acta. 2000 Feb 9;1476(2):265-78. doi: 10.1016/s0167-4838(99)00234-4.
In humans, the crystallin proteins of the ocular lens become yellow-coloured and fluorescent with ageing. With the development of senile nuclear cataract, the crystallins become brown and additional fluorophores are formed. The mechanism underlying crystallin colouration is not known but may involve interaction with kynurenine-derived UV filter compounds. We have recently identified a sulphur-linked glutathionyl-3-hydroxykynurenine glucoside adduct in the lens and speculated that kynurenine may also form adducts with GSH and possibly with nucleophilic amino acids of the crystallins (e.g. Cys). Here we show that kynurenine modifies calf lens crystallins non-oxidatively to yield coloured (365 nm absorbing), fluorescent (Ex 380 nm/Em 450-490 nm) protein adducts. Carboxymethylation and succinylation of crystallins inhibited kynurenine-mediated modification by approx. 90%, suggesting that Cys, Lys and possibly His residues may be involved. This was confirmed by showing that kynurenine formed adducts with GSH as well as with poly-His and poly-Lys. NMR studies revealed that the novel poly-Lys-kynurenine covalent linkage was via the epsilon-amino group of the Lys side chain and the betaC of the kynurenine side chain. Analysis of tryptic peptides of kynurenine-modified crystallins revealed that all of the coloured peptides contained either His, Cys or an internal Lys residue. We propose a novel mechanism of kynurenine-mediated crystallin modification which does not require UV light or oxidative conditions as catalysts. Rather, we suggest that the side chain of kynurenine-derived lens UV filters becomes deaminated to yield an alpha,beta-unsaturated carbonyl which is highly susceptible to attack by nucleophilic amino acid residues of the crystallins. The inability of the lens fibre cells to metabolise their constituent proteins results in the accumulation of coloured/fluorescent crystallins with age.
在人类中,随着年龄增长,眼晶状体中的晶状体蛋白会变黄并产生荧光。随着老年性核性白内障的发展,晶状体蛋白会变成褐色并形成额外的荧光团。晶状体蛋白变色的机制尚不清楚,但可能涉及与犬尿氨酸衍生的紫外线过滤化合物的相互作用。我们最近在晶状体中鉴定出一种硫连接的谷胱甘肽基-3-羟基犬尿氨酸葡萄糖苷加合物,并推测犬尿氨酸也可能与谷胱甘肽以及晶状体蛋白的亲核氨基酸(如半胱氨酸)形成加合物。在这里,我们表明犬尿氨酸非氧化地修饰小牛晶状体蛋白,产生有色(在365nm处吸收)、荧光(激发波长380nm/发射波长450 - 490nm)的蛋白质加合物。晶状体蛋白的羧甲基化和琥珀酰化抑制了犬尿氨酸介导的修饰约90%,表明半胱氨酸、赖氨酸以及可能的组氨酸残基可能参与其中。这通过证明犬尿氨酸与谷胱甘肽以及多聚组氨酸和多聚赖氨酸形成加合物得到了证实。核磁共振研究表明,新型的多聚赖氨酸 - 犬尿氨酸共价键是通过赖氨酸侧链的ε-氨基和犬尿氨酸侧链的βC形成的。对犬尿氨酸修饰的晶状体蛋白的胰蛋白酶肽段分析表明,所有有色肽段都含有组氨酸、半胱氨酸或内部赖氨酸残基。我们提出了一种犬尿氨酸介导的晶状体蛋白修饰的新机制,该机制不需要紫外线或氧化条件作为催化剂。相反,我们认为犬尿氨酸衍生的晶状体紫外线过滤剂的侧链脱氨产生α,β-不饱和羰基,该羰基极易受到晶状体蛋白亲核氨基酸残基的攻击。晶状体纤维细胞无法代谢其组成蛋白导致随着年龄增长有色/荧光晶状体蛋白的积累。